The Future Of The Neurology Devices Market To 2016 – Market Forecasts, Competitive Landscape And Pipeline Analysis

GBI Research's report, "The Future of the Neurology7.1.2 NeuroPro Technologies: Deep Brain Stimulation 58
Devices Market to 2016 - Market Forecasts,7.1.3 Brainsway: Deep TMS H System 58
Competitive Landscape and Pipeline Analysis" provides7.1.4 Cyberonics: Direct Deep Brain Stimulation 58
key data, information and analysis on the global7.1.5 Intelect Medical: Enspire DBS Therapy system
neurology devices market, a key segment within thefor stroke 58
medical device industry. This medical device report7.1.6 Intelect Medical: Enspire Deep Stimulation
provides market landscape, competitive landscapetherapy system 58
and market trends information on five neurology7.1.7 St. Jude Medical: Libra Deep Brain Stimulation
devices market categories - CSF Management,System 59
Neurosurgical Products, Neurostimulation Devices,7.1.8 St. Jude Medical: Libra Deep Brain Stimulation
Interventional Neurology and Radiosurgery. TheSystem-depression 59
report provides comprehensive information on the7.1.9 St. Jude Medical: Libra Deep Brain Stimulation
key trends affecting these categories, and keySystem-essential tremor 59
analytical content on the market dynamics. The7.1.10 St. Jude Medical: LibraXP Deep Brain Stimulation
report also reviews the competitive landscape, keySystem 59
pipeline products and technology offerings.7.1.11 The Magstim Company Limited: Magstim Rapid
This report is built using data and information sourced59
from proprietary databases, primary and secondary7.1.12 Cleveland Medical Devices: ParkinTune 60
research and in-house analysis by GBI Research's7.1.13 Northstar Neuroscience: Renova-DT Cortical
team of industry experts.Stimulation System 60
Scope7.1.14 Duke University: Spinal Cord Stimulator 60
• Key geographies covered include the US (United7.1.15 DynaMed Systems: Traxon 60
States), Canada, the UK (United Kingdom), Germany,7.1.16 Cyberonics: 3T MRI Safe Lead 60
France, Italy, Spain, Japan, China, India, Australia, and7.1.17 Cyberonics: Nerve Wrap 61
Brazil.7.1.18 Cyberonics: Next Generation Programmer-VNS
• Market size and company share data for fivetherapy 61
neurology devices market categories – Cerebro7.1.19 Cyberonics: Next Generation Wand-VNS
Spinal Fluid (CSF) Management, Neurosurgicaltherapy 61
Products, Neurostimulation Devices, Interventional7.1.20 Cyberonics: NXT HC-Pulse Generator 61
Neurology and Radiosurgery.7.1.21 Cyberonics: NXT NP-Pulse Generator 61
• Annualized market revenues data from 2002 to7.1.22 Cyberonics: NXT SR-Pulse Generator 61
2009, forecast forward for 7 years to 2016.7.1.23 Boston Scientific Corporation: Precision
Company shares data for 2008.Implantable neurostimulator 62
• Qualitative analysis of key market trends,7.1.24 MICROTRANSPONDER: Wireless Vagus Nerve
market drivers, and restraints by each categoryStimulator 62
within the neurology devices market.7.2 Interventional Neurology 63
• The report also covers information on the7.2.1 Neurovasx: cPAX Aneurysm Treatment System
leading market players, the competitive landscape,63
and the leading pipeline products and technologies.7.2.2 ev3: Pipeline Embolization Device 64
• Key players covered include Medtronic, Boston7.2.3 BioCure: GelCoil 64
Scientific, Cordis, St. Jude Medical, Cyberonics, ev3,7.2.4 Micrus Endovascular Corporation: Occlusion
Elekta, Accuray, B. Braun, and Codman &balloons 64
Shurtleff.7.2.5 Micrus Endovascular Corporation: Cerecyte
Reasons to buyMicrocoil 64
• Develop business strategies by understanding7.2.6 Micrus Endovascular Corporation: InterPaq
the trends and developments that are driving theMicrocoil 64
neurology devices market globally.7.2.7 Micrus Endovascular Corporation: MicruSphere
• Design and develop your product development,Microcoil 64
marketing and sales strategies.7.2.8 Micrus Endovascular Corporation: UltiPaq Microcoil
• Exploit M&A opportunities by identifying65
market players with the most innovative pipeline.7.2.9 Micrus Endovascular Corporation: Liquid embolic
• Develop market-entry and market expansionproduct 65
strategies.7.2.10 Valor Medical: Neucrylate 65
• Identify key players best positioned to take7.2.11 Surpass Medical Ltd: Brain Aneurysm Occluder
advantage of the emerging market opportunities.65
• Exploit in-licensing and out-licensing opportunities7.2.12 Micrus Endovascular Corporation: Flow diversion
by identifying products, most likely to ensure atechnology 65
robust return.7.2.13 W. L. Gore & Associates: GORE Embolic
• What's the next being thing in the neurologyFilter 66
devices market landscape? – Identify, understand7.2.14 ev3: Solitaire FR Revascularization Device 66
and capitalize.7.3 CSF Management 66
• Make more informed business decisions from7.3.1 NeuroDx Development LLC: ICP Check 66
the insightful and in-depth analysis of the global7.3.2 Neuro Diagnostic Devices: Implantable ICP
neurology devices market and the factors shaping it.monitor 66
1 Table of Contents7.3.3 University of Cincinnati: Smart Sensor 67
1.1 List of Tables 67.3.4 University Hospital Zurich: SmartShunt 67
1.2 List of Figures 77.3.5 CSF Therapeutics: CSF Therapeutic device 67
2 Introduction 87.3.6 NeuroSystems, LLC: Multimodality monitoring 67
2.1 GBI Research Guidance 87.3.7 Biosan Medical Ltd: Ventritek105 67
3 Neurology Devices: Market Characterization 97.4 Neurosurgical Products 68
3.1 Global Neurology Devices Market, Revenue ($7.4.1 Xylos Corporation: Dura replacement product 68
billion), 2002 – 2009 97.4.2 JetGuide Ltd: JetGuide-Neuro 68
3.2 Global Neurology Devices Market, Revenue7.4.3 NICO Corporation: Myriad System 68
Forecast ($ billion),  2009 – 2016 107.4.4 Renishaw plc: Neuroenhance 68
3.3 Global Neurology Devices Market, Key Trends 107.4.5 Renishaw plc: Neurolocate 68
3.3.1 Technological Advances to be a Mainstay in the8 Global Neurology Devices Market: Consolidation
Neurology Devices Market 10Landscape 69
3.3.2 Neurology Devices Market is Increasingly8.1 Deals by Volume, 2006 – 2009 69
Attracting Interest from Cardiovascular Device8.2 Key Deals in 2009 71
Companies 118.2.1 ev3 Completes Acquisition Of Chestnut Medical
3.3.3 Remote Patient Monitoring is a Distinct Possibility71
in near Future 118.2.2 St. Jude Medical Acquires Northstar Neuroscience
3.4 Neurology Devices, Market Dynamics 1172
3.4.1 Market Drivers 119 Appendix 73
3.4.2 Market Restraints 129.1 Definitions 73
3.5 Global Neurology Devices Market, Key Company9.1.1 Neurology Devices 73
Share (%), 2008 149.2 Acronyms 74
4 Global Neurology Devices Market: Category Analysis9.3 Research Methodology 75
and Forecasts 159.3.1 Secondary Research 75
4.1 Neurostimulation Devices 159.3.2 Primary Research 76
4.2 Neurostimulation Devices Market, Global, Revenue9.3.3 Models 76
($m), 2002 – 2009 169.3.4 Forecasts 76
4.3 Neurostimulation Devices Market, Global, Revenue9.3.5 Expert Panels 76
Forecast ($m), 2009 – 2016 179.4 Contact Us 77
4.4 Neurostimulation Devices: Market Dynamics 179.5 Disclaimer 77
4.4.1 Market Drivers 171.1 List of Tables
4.4.2 Market Restraints 19Table 1: Neurology Devices Market, Global, Revenue
4.5 Neurostimulation Devices Market, Global, Company($ billion), 2002 – 2009 9
Shares (%), 2008 20Table 2: Neurology Devices Market, Global, Revenue
4.6 Interventional Neurology 20($ billion), 2009 – 2016 10
4.7 Interventional Neurology Market, Global, RevenueTable 3: Healthcare Expenditure as Percentage of
($m), 2002 – 2009 21GDP, Top 12 Countries, 2008 13
4.8 Interventional Neurology Market, Global, RevenueTable 4: Neurology Devices Market, Global, Company
Forecast ($m),  2009 – 2016 22Share (%), 2008 14
4.9 Interventional Neurology: Market Dynamics 22Table 5: Neurostimulation Devices Market, Global,
4.9.1 Market Drivers 22Revenue ($m), 2002 – 2009 16
4.9.2 Market Restraints 23Table 6: Neurostimulation Devices Market, Global,
4.10 Interventional Neurology Market, Global,Overall Revenues ($m), 2009 – 2016 17
Company Shares (%), 2008 24Table 7: 65 and older population (m), Global,
4.11 CSF Management 24Percentage of 65 and older population, 2008 –
4.12 CSF Management Market, Global, Revenue ($m),2015 19
2002 – 2009 25Table 8: Neurostimulation Devices Market, Global,
4.13 Global CSF Management Market, RevenueCompany Share (%), 2008 20
Forecasts ($m), 2009 – 2016 26Table 9: Interventional Neurology Market, Global,
4.14 CSF Management: Market Dynamics 26Revenue ($m), 2002 – 2009 21
4.14.1 Market Driver: Hydrocephalus Prevalence toTable 10: Interventional Neurology Market, Global,
Drive the Market in the Future 26Revenue ($m), 2009 – 2016 22
4.14.2 Market Restraint: Lack of Accurate Diagnosis isTable 11: Interventional Neurology Market, Global,
Slowing the Market Growth 27Company Share (%), 2008 24
4.15 Global CSF Management Market, Global,Table 12: CSF Management Market, Global, Revenue
Company Shares (%), 2008 27($m), 2002 – 2009 25
4.16 Neurosurgical Products 27Table 13: CSF Management Market, Global, Revenue
4.17 Neurosurgical Products Market, Global, Revenue($m), 2009 – 2016 26
($m), 2002 – 2009 28Table 14: CSF Management Market, Global, Company
4.18 Neurosurgical Products Market, Global, RevenueShares (%), 2008 27
Forecast ($m),  2009 – 2016 29Table 15: Neurosurgical Products Market, Global,
4.19 Neurosurgical Products: Market Dynamics 29Revenue ($m), 2002 – 2009 28
4.19.1 Market Drivers 29Table 16: Neurosurgical Products Market, Global,
4.19.2 Market Restraints: Technical Difficulties inRevenue ($m), 2009 – 2016 29
Performing the Procedure and Advent of VentricularTable 17: Neurosurgical Products Market, Global,
Shunts is Slowing the Market Growth 30Company Share (%), 2008 30
4.20 Global Neurosurgical Products Market, KeyTable 18: Radiosurgery Market, Global, Revenue ($m),
Company Shares (%), 2008 302002 – 2009 31
4.21 Radiosurgery 31Table 19: Radiosurgery Market, Global, Overall
4.22 Global Radiosurgery Market, Global, RevenueRevenues ($m), 2009 – 2016 32
($m), 2002 – 2009 31Table 20: Radiosurgery Market, Global, Company
4.23 Global Radiosurgery Market, Revenue ForecastsShare (%), 2008 34
($m), 2009 – 2016 32Table 21: Neurology Devices Market, Cross-Country
4.24 Radiosurgery: Market Dynamics 32Analysis, Global, 2002 – 2016 35
4.24.1 Market Drivers 32Table 22: Neurology Devices Market, US, Overall
4.24.2 Market Restraint: High Cost of RadiosurgeryRevenues ($ bn), 2002 – 2009 36
Systems is Slowing the Purchasing Decision of theTable 23: Neurology Devices Market, Canada, Overall
Hospitals 33Revenues ($ bn), 2002 – 2009 37
4.25 Global Radiosurgery Market, Key CompanyTable 24: Neurology Devices Market, UK, Overall
Shares (%), 2008 33Revenues ($ bn), 2002 – 2009 37
5 Global Neurology Devices Market: Country AnalysisTable 25: Neurology Devices Market, Germany,
and Forecasts 35Overall Revenues ($ bn), 2002 – 2009 38
5.1 Neurology Devices Market: Cross-Country AnalysisTable 26: Neurology Devices Market, France, Overall
35Revenues ($ bn), 2002 – 2009 39
5.2 Revenue, By Country, 2002 – 2009 36Table 27: Neurology Devices Market, Italy, Overall
5.2.1 The US Neurology Devices Market, RevenuesRevenues ($ bn), 2002 – 2009 39
($m), 2002 – 2009 36Table 28: Neurology Devices Market, Spain, Overall
5.2.2 Canada Neurology Devices Market, RevenuesRevenues ($ bn), 2002 – 2009 40
($m), 2002 – 2009 36Table 29: Neurology Devices Market, Japan, Overall
5.2.3 The UK Neurology Devices Market, RevenuesRevenues ($ bn), 2002 – 2009 41
($m), 2002 – 2009 37Table 30: Neurology Devices Market, China, Overall
5.2.4 Germany Neurology Devices Market, RevenuesRevenues ($ bn), 2002 – 2009 41
($m), 2002 – 2009 38Table 31: Neurology Devices Market, India, Overall
5.2.5 France Neurology Devices Market, RevenuesRevenues ($ bn), 2002 – 2009 42
($m), 2002 – 2009 38Table 32: Neurology Devices Market, Australia, Overall
5.2.6 Italy Neurology Devices Market, Revenues ($m),Revenues ($ bn), 2002 – 2009 43
2002 – 2009 39Table 33: Neurology Devices Market, Brazil, Overall
5.2.7 Spain Neurology Devices Market, RevenuesRevenues ($ bn), 2002 – 2009 43
($m), 2002 – 2009 40Table 34: Neurology Devices Market, US, Overall
5.2.8 Japan Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 44
($m), 2002 – 2009 40Table 35: Neurology Devices Market, Canada, Overall
5.2.9 China Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 45
($m), 2002 – 2009 41Table 36: Neurology Devices Market, UK, Overall
5.2.10 India Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 45
($m), 2002 – 2009 42Table 37: Neurology Devices Market, Germany,
5.2.11 Australia Neurology Devices Market, RevenuesOverall Revenues ($m), 2009 – 2016 46
($m), 2002 – 2009 42Table 38: Neurology Devices Market, France, Overall
5.2.12 Brazil Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 47
($m), 2002 – 2009 43Table 39: Neurology Devices Market, Italy, Overall
5.3 Revenue Forecasts, By Country, 2009 – 2016Revenues ($m), 2009 – 2016 47
44Table 40: Neurology Devices Market, Spain, Overall
5.3.1 The US Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 48
($m), 2009 – 2016 44Table 41: Neurology Devices Market, Japan, Overall
5.3.2 Canada Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 49
($m), 2009 – 2016 44Table 42: Neurology Devices Market, China, Overall
5.3.3 The UK Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 49
($m), 2009 – 2016 45Table 43: Neurology Devices Market, India, Overall
5.3.4 Germany Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 50
($m), 2009 – 2016 46Table 44: Neurology Devices Market, Australia, Overall
5.3.5 France Neurology Devices Market, RevenuesRevenues ($m), 2009 – 2016 51
($m), 2009 – 2016 46Table 45: Neurology Devices Market, Brazil, Overall
5.3.6 Italy Neurology Devices Market, Revenues ($m),Revenues ($m), 2009 – 2016 51
2009 – 2016 47Table 46: Company - Product Matrix, Neurology
5.3.7 Spain Neurology Devices Market, RevenuesDevices Market, 2009 52
($m), 2009 – 2016 48Table 47: Medtronic, Key Products, Neurology
5.3.8 Japan Neurology Devices Market, RevenuesDevices, Global, 2009 53
($m), 2009 – 2016 48Table 48: Boston Scientific Corporation, Key Products,
5.3.9 China Neurology Devices Market, RevenuesNeurology Devices, Global, 2009 54
($m), 2009 – 2016 49Table 49: St. Jude Medical, Key Products, Neurology
5.3.10 India Neurology Devices Market, RevenuesDevices, Global, 2009 55
($m), 2009 – 2016 50Table 50: Cordis Corporation, Key Products,
5.3.11 Australia Neurology Devices Market, RevenuesNeurology Devices, Global, 2009 55
($m), 2009 – 2016 50Table 51: ev3, Key Products, Neurology Devices,
5.3.12 Brazil Neurology Devices Market, RevenuesGlobal, 2009 56
($m), 2009 – 2016 51Table 52: Neurostimulation Devices, Pipeline Products,
6 Global Neurology Devices Market: Competitive2009 57
Assessment 52Table 53: Interventional Neurology, Pipeline Products,
6.1 Medtronic 522009 63
6.2 Boston Scientific Corporation 53Table 54: CSF Management, Pipeline Products, 2009
6.3 St. Jude Medical 5466
6.4 Cordis Corporation 55Table 55: Neurosurgical Products, Pipeline Products,
6.5 ev3 552009 68
7 Global Neurology Devices Market: Product PipelineTable 56: Neurology Devices Market, Mergers &
Analysis 57Acquisitions, by Volume, Global,  2006 – 2009 69
7.1 Neurostimulation Devices 57Table 57: Neurology Devices Market, Mergers &
7.1.1 Boston Scientific Corporation: Bion MicrostimulatorAcquisitions, Global, 2006 – 2009 70
System 581.